Author:
Smith Theodore A. G.,Mehaffey Michele G.,Kayda Dawn B.,Saunders June M.,Yei Soonpin,Trapnell Bruce C.,McClelland Alan,Kaleko Michael
Publisher
Springer Science and Business Media LLC
Reference34 articles.
1. Thompson, A.R. Stucture, function, and molecular defects of factor IX. Blood 67, 565–572 (1986).
2. Prevention and control of haemophilia: Memorandum from a joint WHO/WFA meeting. Bull. World Health Org. 69, 17–26 (1991).
3. Briet, E. Factor IX inhibitors in haemophilia B patients: their incidence and prospects for development with high purity factor IX products. Blood Coag. Fibrin. 2, (suppl 1) 47–50 (1991).
4. Hedner, U. & Davie, E.W. Introduction to hemostasis and the vitamin K dependent coagulation factors in The Metabolic Basis of Inherited Diseases Vol. 2, 6 edn (eds Scriver, C. R. et al.) 2116–2134 (McGraw-Hill, New York, N.Y. 1989).
5. Palmer, T.D., Thompson, A.R. & Miller, A.D. Production of Human factor IX in animals by genetically modified skin fibroblasts: potential therapy for hemophilia B. Blood 73, 438–445 (1989).
Cited by
338 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献